ArticleResearch square2025

An intranasal adjuvanted, recombinant influenza A/H5 vaccine candidate induces broad priming against diverse influenza A/H5N1 virus clades in a phase I randomized trial in healthy adults.

Meagan E Deming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.